Approval of esketamine for treatment-resistant depression - Authors' reply
Lancet Psychiatry
.
2020 Mar;7(3):235-236.
doi: 10.1016/S2215-0366(20)30040-7.
Authors
Florian Naudet
1
,
Ioana A Cristea
2
Affiliations
1
Centre d'Investigation Clinique de Rennes, University Rennes, CHU Rennes, Inserm, CIC 1414, Rennes, France.
2
Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy. Electronic address: ioana.cristea@unipv.it.
PMID:
32087802
DOI:
10.1016/S2215-0366(20)30040-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Depression
Depressive Disorder, Treatment-Resistant*
Humans
Ketamine*
Substances
Esketamine
Ketamine